These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36539978)

  • 1. A viewpoint on aldosterone and BMI related brain morphology in relation to treatment outcome in patients with major depression.
    Murck H; Lehr L; Jezova D
    J Neuroendocrinol; 2023 Feb; 35(2):e13219. PubMed ID: 36539978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: a translational approach.
    Heinzmann JM; Kloiber S; Ebling-Mattos G; Bielohuby M; Schmidt MV; Palme R; Holsboer F; Uhr M; Ising M; Touma C
    Psychoneuroendocrinology; 2014 Nov; 49():229-43. PubMed ID: 25123105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression.
    Büttner M; Jezova D; Greene B; Konrad C; Kircher T; Murck H
    J Psychiatr Res; 2015; 66-67():24-37. PubMed ID: 25959615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic, molecular and clinical determinants for the involvement of aldosterone and its receptors in major depression.
    Murck H; Büttner M; Kircher T; Konrad C
    Nephron Physiol; 2014; 128(1-2):17-25. PubMed ID: 25376974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of mineralocorticoid receptor function: changes over time and relationship to response in patients with major depression.
    Murck H; Braunisch MC; Konrad C; Jezova D; Kircher T
    Int Clin Psychopharmacol; 2019 Jan; 34(1):18-26. PubMed ID: 30300165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects.
    Künzel HE; Zobel AW; Nickel T; Ackl N; Uhr M; Sonntag A; Ising M; Holsboer F
    J Psychiatr Res; 2003; 37(6):525-33. PubMed ID: 14563384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.
    Lembke A; Gomez R; Tenakoon L; Keller J; Cohen G; Williams GH; Kraemer FB; Schatzberg AF
    Psychoneuroendocrinology; 2013 Jan; 38(1):115-21. PubMed ID: 22727477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
    Keller J; Gomez R; Williams G; Lembke A; Lazzeroni L; Murphy GM; Schatzberg AF
    Mol Psychiatry; 2017 Apr; 22(4):527-536. PubMed ID: 27528460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression.
    Hatzinger M
    World J Biol Psychiatry; 2000 Apr; 1(2):105-11. PubMed ID: 12607206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
    Mocking RJ; Verburg HF; Westerink AM; Assies J; Vaz FM; Koeter MW; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin as a target for antidepressant development: an assessment of the available evidence.
    Scott LV; Dinan TG
    J Affect Disord; 2002 Nov; 72(2):113-24. PubMed ID: 12200202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.
    Lamers F; Vogelzangs N; Merikangas KR; de Jonge P; Beekman AT; Penninx BW
    Mol Psychiatry; 2013 Jun; 18(6):692-9. PubMed ID: 23089630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of childhood abuse on cortisol levels and the cortisol awakening response in depressed and nondepressed older adults.
    Wielaard I; Schaakxs R; Comijs HC; Stek ML; Rhebergen D
    World J Biol Psychiatry; 2018 Sep; 19(6):440-449. PubMed ID: 28120636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.
    Baghai TC; Schule C; Zwanzger P; Minov C; Zill P; Ella R; Eser D; Oezer S; Bondy B; Rupprecht R
    Neurosci Lett; 2002 Aug; 328(3):299-303. PubMed ID: 12147330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation: What the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control.
    Suarez EC; Sundy JS; Erkanli A
    Brain Behav Immun; 2015 Feb; 44():137-47. PubMed ID: 25241020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
    Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
    J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.